LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Heterozygous carriers of classical homocystinuria tend to have higher fasting serum homocysteine concentrations than non-carriers in the presence of folate deficiency.

    Lu, Yung-Hsiu / Cheng, Li-Mei / Huang, Yu-Hsiu / Lo, Ming-Yu / Wu, Tina Jui-Ting / Lin, Hsiang-Yu / Hsu, Ting-Rong / Niu, Dau-Ming

    Clinical nutrition (Edinburgh, Scotland)

    2015  Volume 34, Issue 6, Page(s) 1155–1158

    Abstract: Background & aims: Many studies have reported that serum total homocysteine (tHcy) levels in cystathionine-beta-synthase (CBS) carriers are usually normal and only elevated after a methionine load. However, the amount of methionine required for a ... ...

    Abstract Background & aims: Many studies have reported that serum total homocysteine (tHcy) levels in cystathionine-beta-synthase (CBS) carriers are usually normal and only elevated after a methionine load. However, the amount of methionine required for a loading test is non-physiological and is never reached with regular feeding. Therefore, CBS carriers do not seem to be at an increased risk of cardiovascular diseases. However, the risk of cardiovascular diseases of CBS carriers with folate deficiency has not been studied. We recently found an extraordinarily high carrier rate (1/7.78) of a novel CBS mutation (p.D47E, c.T141A) in an Austronesian Taiwanese Tao tribe who live in a geographic area with folate deficiency. We evaluated if the CBS carriers tend to have higher fasting serum tHcy concentrations than non-carriers in presence of folate deficiency.
    Methods: The serum tHcy and folate levels before and after folate replacement were measured in 48 adult Tao carriers, 40 age-matched Tao non-carriers and 40 age-matched Han Taiwanese controls.
    Results: The serum tHcy level of the Tao CBS carriers (17.9 ± 3.8 μmol/l) was significantly higher than in Tao non-carriers (15.7 ± 3.5 μmol/l; p < 0.008) and Taiwanese controls (11.8 ± 2.9 μmol/l; p < 0.001). Furthermore, a high prevalence of folate deficiency in the Tao compared with the Taiwanese controls (4.9 ± 1.8 ng/ml vs. 10.6 ± 5.5 ng/ml; p < 0.001) was also noted. Of note, the difference in tHcy levels between the carriers and non-carriers was eliminated by folate supplementation. (carriers:13.65 ± 2.13 μmol/l; non-carriers:12.39 ± 3.25 μmol/l, p = 0.321).
    Conclusions: CBS carriers tend to have a higher tHcy level in the presence of folate deficiency than non-carriers. Although many reports have indicated that CBS carriers are not associated with cardiovascular disease, the risk for CBS carriers with folate deficiency has not been well studied. Owing to a significantly elevated level of fasting tHcy without methionine loading, it is important to evaluate the risk of cardiovascular disease in CBS carriers with folate deficiency.
    MeSH term(s) Aged ; Cardiovascular Diseases/blood ; Case-Control Studies ; Cystathionine beta-Synthase/blood ; Cystathionine beta-Synthase/genetics ; Dietary Supplements ; Fasting ; Female ; Folic Acid/administration & dosage ; Folic Acid/blood ; Folic Acid Deficiency/blood ; Folic Acid Deficiency/epidemiology ; Genotyping Techniques ; Heterozygote ; Homocysteine/blood ; Homocystinuria/blood ; Homocystinuria/genetics ; Humans ; Male ; Methionine/administration & dosage ; Methionine/blood ; Methylenetetrahydrofolate Reductase (NADPH2)/blood ; Middle Aged ; Prevalence ; Risk Factors ; Taiwan ; Vitamin B 12/blood
    Chemical Substances Homocysteine (0LVT1QZ0BA) ; Folic Acid (935E97BOY8) ; Methionine (AE28F7PNPL) ; MTHFR protein, human (EC 1.5.1.20) ; Methylenetetrahydrofolate Reductase (NADPH2) (EC 1.5.1.20) ; Cystathionine beta-Synthase (EC 4.2.1.22) ; Vitamin B 12 (P6YC3EG204)
    Language English
    Publishing date 2015-12
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604812-2
    ISSN 1532-1983 ; 0261-5614
    ISSN (online) 1532-1983
    ISSN 0261-5614
    DOI 10.1016/j.clnu.2014.11.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Homocystinuria in Taiwan: an inordinately high prevalence in an Austronesian aboriginal tribe, Tao.

    Lu, Yung-Hsiu / Huang, Yu-Hsiu / Cheng, Li-Mei / Yu, Hsiao-Chi / Hsu, Ju-Hui / Wu, Tina Jui-Ting / Lo, Ming-Yu / Lin, Andrew / Lin, Ching-Yuang / Wu, Jer-Yuarn / Niu, Dau-Ming

    Molecular genetics and metabolism

    2012  Volume 105, Issue 4, Page(s) 590–595

    Abstract: The newborn screening of homocystinuria in Taiwan has never been formally reported before. Since 1984, out of 5 million newborns screened, only 3 newborns (Han Taiwanese) suffering from homocystinuria were detected in this newborn screening program. Four ...

    Abstract The newborn screening of homocystinuria in Taiwan has never been formally reported before. Since 1984, out of 5 million newborns screened, only 3 newborns (Han Taiwanese) suffering from homocystinuria were detected in this newborn screening program. Four mutations (p.R121L [c.362G>T], p.E176K [c.526G>A], p.V320G [c.959T>G] and p.G259D [c.776G>A]) were identified in these 3 patients. Unexpectedly, we recently found 8 patients presenting with homocystinuria in an Austronesian Taiwanese Tao tribe. Out of them, three patients participated in the newborn screening program but were unidentified by the current newborn homocystinuria (using methionine as a marker) screening. All the Tao patients are homozygous for a new p.D47E (c.141T>A) mutation. Among the 428 adult islanders screened for the D47E mutation, approximately 1 in 7.78 is a carrier of the mutation, and an estimated 1 in 240 islanders suffered from homocystinuria. This is the highest known prevalence of homocystinuria worldwide. The result of expression studies of all the mutations identified in Taiwan revealed that, except for p.D47E mutation, all mutations were severely limited in their ability to form functional tetramers. The clinical manifestations of the Tao patients varied widely, despite sharing the same mutation and very similar genetic and environmental backgrounds. Comparisons of clinical and biochemical phenotypes of these patients were presented in this report.
    MeSH term(s) Adolescent ; Adult ; Blotting, Western ; Cells, Cultured ; Child ; Cystathionine beta-Synthase/genetics ; DNA Mutational Analysis ; Fibroblasts/cytology ; Fibroblasts/enzymology ; Heterozygote ; Homocystinuria/diagnosis ; Homocystinuria/epidemiology ; Homocystinuria/genetics ; Homozygote ; Humans ; Infant, Newborn ; Mutagenesis, Site-Directed ; Mutation/genetics ; Neonatal Screening ; Prevalence ; Real-Time Polymerase Chain Reaction ; Taiwan/epidemiology
    Chemical Substances Cystathionine beta-Synthase (EC 4.2.1.22)
    Language English
    Publishing date 2012-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1418518-0
    ISSN 1096-7206 ; 1096-7192
    ISSN (online) 1096-7206
    ISSN 1096-7192
    DOI 10.1016/j.ymgme.2012.01.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Homocystinuria in Taiwan: An inordinately high prevalence in an Austronesian aboriginal tribe, Tao

    Lu, Yung-Hsiu / Huang, Yu-Hsiu / Cheng, Li-Mei / Yu, Hsiao-Chi / Hsu, Ju-Hui / Wu, Tina Jui-Ting / Lo, Ming-Yu / Lin, Andrew / Lin, Ching-Yuang / Wu, Jer-Yuarn / Niu, Dau-Ming

    Molecular genetics and metabolism. 2012 Apr., v. 105, no. 4

    2012  

    Abstract: The newborn screening of homocystinuria in Taiwan has never been formally reported before. Since 1984, out of 5million newborns screened, only 3 newborns (Han Taiwanese) suffering from homocystinuria were detected in this newborn screening program. Four ... ...

    Abstract The newborn screening of homocystinuria in Taiwan has never been formally reported before. Since 1984, out of 5million newborns screened, only 3 newborns (Han Taiwanese) suffering from homocystinuria were detected in this newborn screening program. Four mutations (p.R121L [c.362G>T], p.E176K [c.526G>A], p.V320G [c.959T>G] and p.G259D [c.776G>A]) were identified in these 3 patients. Unexpectedly, we recently found 8 patients presenting with homocystinuria in an Austronesian Taiwanese Tao tribe. Out of them, three patients participated in the newborn screening program but were unidentified by the current newborn homocystinuria (using methionine as a marker) screening. All the Tao patients are homozygous for a new p.D47E (c.141T>A) mutation. Among the 428 adult islanders screened for the D47E mutation, approximately 1 in 7.78 is a carrier of the mutation, and an estimated 1 in 240 islanders suffered from homocystinuria. This is the highest known prevalence of homocystinuria worldwide. The result of expression studies of all the mutations identified in Taiwan revealed that, except for p.D47E mutation, all mutations were severely limited in their ability to form functional tetramers. The clinical manifestations of the Tao patients varied widely, despite sharing the same mutation and very similar genetic and environmental backgrounds. Comparisons of clinical and biochemical phenotypes of these patients were presented in this report.
    Keywords adults ; homocystinuria ; homozygosity ; methionine ; mutation ; neonates ; patients ; phenotype ; screening ; Taiwan
    Language English
    Dates of publication 2012-04
    Size p. 590-595.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 1418518-0
    ISSN 1096-7206 ; 1096-7192
    ISSN (online) 1096-7206
    ISSN 1096-7192
    DOI 10.1016/j.ymgme.2012.01.021
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top